Search
EyePoint Pharmaceuticals Inc
EYPTAdd to Watchlist
12.190USD
-0.280-2.25%
Close 07-24 16:00（ET）Quotes delayed by 15 min
1.01BMarket Cap
LossP/E TTM
EyePoint Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-24The current valuation score of EyePoint Pharmaceuticals Inc is 6.48, ranking 147 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -3.48, which is -76.07% below the recent high of -0.83 and -369.48% above the recent low of -16.33.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.